Aloe Vera for Blood Sugar and Metabolic Health

A modest but real body of small clinical trials suggests that oral aloe vera gel can lower fasting blood glucose and HbA1c, with the clearest signal in people with prediabetes or newly diagnosed, untreated type 2 diabetes. Several trials also report small improvements in cholesterol and triglycerides. These are genuinely interesting findings — but the trials are small, short, and inconsistent, the aloe products are poorly standardized, and there are no long-term or hard-outcome data. This page lays out what the meta-analyses show, why the evidence is still low-certainty, and how to use aloe cautiously without abandoning proven diabetes care.

Table of Contents

  1. The Short Version
  2. Use the Gel, Not the Latex
  3. Proposed Mechanisms
  4. Prediabetes and Early Type 2 Diabetes
  5. Established Type 2 Diabetes
  6. Cholesterol and Triglycerides
  7. Metabolic Syndrome and Weight
  8. Why the Evidence Is Still Weak
  9. Practical Use and Monitoring
  10. Cautions and Drug Interactions
  11. Key Research Papers
  12. Connections
  13. Featured Videos

The Short Version

Pooled analyses of randomized trials suggest oral aloe gel lowers fasting glucose by a clinically meaningful amount in people with impaired glucose control, and modestly lowers HbA1c, especially in prediabetes and early type 2 diabetes. The effect appears smaller or absent in people whose diabetes is already well managed on medication. Because the trials are small and heterogeneous, professional bodies do not recommend aloe as a treatment for diabetes — it is, at most, a possible complementary aid alongside diet, exercise, and prescribed medication.

Back to Table of Contents

Use the Gel, Not the Latex

Every metabolic trial worth citing used purified inner-leaf gel or a standardized extract, not aloe latex. The latex is a stimulant laxative with genotoxicity and other safety concerns and has no place in blood-sugar management. Choose a decolorized, low-aloin, IASC-certified inner-leaf product. The Digestive Health page explains the gel-versus-latex distinction in detail.

Back to Table of Contents

Proposed Mechanisms

Several mechanisms have been proposed, mostly from animal and laboratory work:

These mechanisms are plausible but not firmly established in humans; the honest position is that we observe a glucose-lowering signal in trials without fully understanding why.

Back to Table of Contents

Prediabetes and Early Type 2 Diabetes

This is where the evidence is strongest. A 2016 systematic review and meta-analysis by Suksomboon and colleagues found that aloe improved glycaemic control, with the effect most apparent in people with prediabetes and type 2 diabetes. A separate 2016 meta-analysis by Zhang and colleagues focusing on prediabetes and early, non-treated diabetic patients reached similar conclusions, and a randomized controlled trial by Alinejad-Mofrad and colleagues in prediabetic subjects reported improvements in both glucose and lipid profile. Devaraj and colleagues likewise reported metabolic improvements in people with prediabetes and metabolic syndrome. The pattern — biggest benefit before medication is started — is consistent across these studies. For the condition, see our Prediabetes page.

Back to Table of Contents

Established Type 2 Diabetes

A 2016 meta-analysis by Dick and colleagues pooling trials of oral aloe reported reductions in fasting glucose and HbA1c, though the effect sizes varied widely between studies and the confidence intervals were wide. A 2021 overview of systematic reviews by Araya-Quintanilla and colleagues was more cautious, rating the overall certainty of evidence as low and calling for larger, better-conducted trials. In practice this means aloe may add a small amount to glucose control in some people with type 2 diabetes, but it is not a reliable, predictable treatment and must never replace metformin, other medications, or lifestyle therapy. See our Type 2 Diabetes page and Insulin Resistance page.

Back to Table of Contents

Cholesterol and Triglycerides

Some of the same trials that measured glucose also reported small reductions in total cholesterol, LDL cholesterol, and triglycerides with oral aloe, particularly in people with prediabetes or metabolic syndrome. The lipid findings are less consistent than the glucose findings and, again, come from small studies. Aloe is not a substitute for statin therapy where that is indicated, but a favorable nudge in lipids is a plausible secondary effect of improving overall metabolic health.

Back to Table of Contents

Metabolic Syndrome and Weight

A 2019 narrative review by Shakib and colleagues summarized aloe's potential role in metabolic syndrome, drawing together the glucose, lipid, and anti-inflammatory strands. A few trials have reported small reductions in body weight or fat mass, but the data are too limited to consider aloe a weight-loss agent. The realistic framing is that aloe might modestly support the cluster of metabolic-syndrome measures (glucose, lipids, possibly weight) as one small piece of a diet-and-exercise-centered plan. See our Metabolic Syndrome page.

Back to Table of Contents

Why the Evidence Is Still Weak

It is worth being explicit about the weaknesses, because the marketing rarely is:

None of this means aloe does nothing — the signal is fairly consistent — but it does mean the appropriate stance is cautious optimism, not confidence.

Back to Table of Contents

Practical Use and Monitoring

Back to Table of Contents

Cautions and Drug Interactions

Back to Table of Contents

Key Research Papers

  1. Suksomboon N, Poolsup N, Punthanitisarn S (2016). Effect of Aloe vera on glycaemic control in prediabetes and type 2 diabetes: a systematic review and meta-analysis. J Clin Pharm Ther. — PubMed PMID: 27009750
  2. Dick WR, Fletcher EA, Shah SA (2016). Reduction of fasting blood glucose and hemoglobin A1c using oral aloe vera: a meta-analysis. J Altern Complement Med. — PubMed PMID: 27152917
  3. Zhang Y, Liu W, Liu D, et al. (2016). Efficacy of aloe vera supplementation on prediabetes and early non-treated diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Nutrients. — PubMed PMID: 27347994
  4. Alinejad-Mofrad S, Foadoddini M, Saadatjoo SA, Shayesteh M (2015). Improvement of glucose and lipid profile status with Aloe vera in pre-diabetic subjects: a randomized controlled-trial. J Diabetes Metab Disord. — PubMed PMID: 25883909
  5. Devaraj S, Yimam M, Brownell LA, et al. (2013). Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome. Metab Syndr Relat Disord. — PubMed PMID: 23035844
  6. Araya-Quintanilla F, Gutierrez-Espinoza H, et al. (2021). Effectiveness of aloe vera in patients with type 2 diabetes mellitus and pre-diabetes: an overview of systematic reviews. Diabetes Metab Syndr. — PubMed PMID: 34563809
  7. Shakib Z, Shahraki N, Razavi BM, Hosseinzadeh H (2019). Aloe vera as an herbal medicine in the treatment of metabolic syndrome: a review. Phytother Res. — PubMed PMID: 31456283
  8. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS (2003). Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. — PubMed PMID: 12663610
  9. Willcox ML, Elugbaju C, Al-Anbaki M, et al. (2021). Effectiveness of medicinal plants for glycaemic control in type 2 diabetes: an overview of meta-analyses of clinical trials. Front Pharmacol. — PubMed PMID: 34899340
  10. Cefalu WT, Ye J, Wang ZQ (2008). Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans. Endocr Metab Immune Disord Drug Targets. — PubMed PMID: 18537692

PubMed Topic Searches

  1. PubMed: Aloe vera type 2 diabetes
  2. PubMed: Aloe vera prediabetes
  3. PubMed: Aloe vera HbA1c meta-analyses
  4. PubMed: Aloe vera lipids / cholesterol
  5. PubMed: Aloe vera metabolic syndrome

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents